The Board of Directors of Alten has decided to separate the roles of Chairman and CEO. Simon Azoulay, who has held both positions, will continue as Chairman of the Board. Cyril Malargé, currently the CEO of Sopra-Steria, will take over as CEO of Alten by no later than January 31, 2026. Malargé, aged 52, holds a degree from the Ecole Spéciale de Mécanique et d'Electricité and a PhD in Electrical Engineering. His career began at Bel Group, followed by a stint at Lafont as CIO, and then at Sopra Steria where he held various leadership positions. Simon Azoulay has expressed his confidence in Malargé to ensure the continuity of Alten's development.
Board Resignation and Succession
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Alten's Board of Directors has also acknowledged the resignation of Aliette Mardyks, an independent director and Chair of the Audit Committee. Danièle Guyot-Caparros has been co-opted to succeed her, both on the Board and as Chair of the Audit Committee, for the remaining duration of the term, which lasts until the general assembly of 2028. Guyot-Caparros, 66, has extensive experience in finance and commercial operations, having worked at PwC and held leadership roles at Rhône-Poulenc-Rorer, now known as Sanofi. She is also a member of the boards of DBV Technologies and Valneva SE.
Official Confirmations Pending
The appointments of Simon Azoulay as Chairman of the Board and Cyril Malargé as CEO will be confirmed in an upcoming official statement from Alten. The ratification of the co-optation of Danièle Guyot-Caparros will be submitted for approval at the company's annual general meeting in 2026. These changes are part of a dynamic to strengthen governance to support Alten's development strategy.
SectorServices aux entreprises · Services industriels · Services IT et conseil›Services Informatiques
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: 9M 2025
Guidance from the release
Ralentissement d'activité persistant entamé au second semestre 2023, contexte macro-économique incertain sans signe tangible de reprise; quelques messages positifs pour 2026. Confirmation d'une décroissance organique 2025 et d'une marge opérationnelle d'activité attendue entre 8 % et 8,1 %.
Risks mentioned
Ralentissement de la demande global
Recul marqué du secteur Automobile
Recul dans les Télécom, Autres Industries, Electronique et secteur Public
Contexte macro-économique incertain
Opportunities identified
Croissance dans les secteurs Défense et Sécurité / Naval, Energie et Ferroviaire
Croissance externe via 3 acquisitions internationales
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.